BCM
EVH icon

Bayesian Capital Management’s Evolent Health EVH Stock Holding History

Bayesian Capital Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-86,446
Closed -$819K – 644
2025
Q1 		$819K Buy
+86,446
New +$873K 0.14% 208
2024
Q4 		– Sell
-76,135
Closed -$2.15M – 777
2024
Q3 		$2.15M Buy
76,135
+49,800
+189% +$1.28M 0.25% 117
2024
Q2 		$504K Buy
26,335
+9,300
+55% +$237K 0.06% 367
2024
Q1 		$559K Buy
+17,035
New +$544K 0.05% 415
2023
Q2 		– Sell
-22,976
Closed -$746K – 865
2023
Q1 		$746K Buy
+22,976
New +$727K 0.09% 292
2022
Q4 		– Sell
-20,489
Closed -$736K – 851
2022
Q3 		$736K Buy
+20,489
New +$722K 0.15% 187
2018
Q1 		– Sell
-17,400
Closed -$214K – 647
2017
Q4 		$214K Buy
+17,400
New +$245K 0.04% 478
2017
Q1 		– Sell
-15,821
Closed -$234K – 494
2016
Q4 		$234K Buy
+15,821
New +$312K 0.06% 481

Other funds holding EVH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bayesian Capital Management's EVH Position: Q2 2025 in Review

Bayesian Capital Management sold out of Evolent Health (EVH) in Q2 2025, closing a stake of 86,446 shares — an estimated $819K sold.

Bayesian Capital Management first reported a position in EVH in Q4 2016 and held it in 8 quarters. The position peaked at $2.15M in Q3 2024. 220 funds tracked by Wall St. Rank hold EVH as of Q2 2025.

  • Bayesian Capital Management reported no remaining Evolent Health position as of Q2 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 86,446 Evolent Health shares in Q2 2025, an estimated $819K.
  • Bayesian Capital Management first reported a position in Evolent Health in Q4 2016 and held it in 8 quarters.
  • Bayesian Capital Management's Evolent Health position peaked at $2.15M in Q3 2024.
  • 220 funds tracked by Wall St. Rank held Evolent Health as of Q2 2025.

Based on Bayesian Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.